Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Mesa Laboratories (MLAB) EBIAT (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed EBIAT for 16 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 316.59% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, up 101.5% year-over-year, with the annual reading at -$2.0 million for FY2025, 99.22% up from the prior year.
  • EBIAT hit $3.6 million in Q4 2025 for Mesa Laboratories, up from $2.5 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $4.7 million in Q2 2025 to a low of -$254.6 million in Q1 2024.
  • Historically, EBIAT has averaged -$12.0 million across 5 years, with a median of $878500.0 in 2022.
  • Biggest YoY gain for EBIAT was 717.12% in 2024; the steepest drop was 35858.05% in 2024.
  • Year by year, EBIAT stood at -$2.1 million in 2021, then surged by 121.89% to $451000.0 in 2022, then skyrocketed by 369.18% to $2.1 million in 2023, then crashed by 179.21% to -$1.7 million in 2024, then soared by 316.59% to $3.6 million in 2025.
  • Business Quant data shows EBIAT for MLAB at $3.6 million in Q4 2025, $2.5 million in Q3 2025, and $4.7 million in Q2 2025.